ArticleScientific reports2026
An online interpretable machine learning model for predicting cardiometabolic multimorbidity risk in patients with type 2 diabetes mellitus.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- How survival time reshapes prognostic risk in giant cell glioblastoma.Discover oncology · 2026Article
- The correlation between the systemic inflammation response index and 6-month readmission risk in patients with hypertensive heart disease-related heart failure and its predictive model.Frontiers in medicine · 2026Article
- Sleep duration, sleep quality, and daytime napping in relation to incident cardiometabolic multimorbidity across three national aging cohorts: a prospective, interpretable machine learning study.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Cardiometabolic multimorbidity (CMM), a major complication in type 2 diabetes mellitus (T2DM), increases mortality and healthcare burden. Early identification of high-risk individuals is crucial for precision intervention. This study aimed to develop and validate an online interpretable machine learning system for forecasting the CMM risk in T2DM populations to facilitate personalized decision-making and early intervention. We used data from 793 T2DM patients from a tertiary hospital in Shanxi Province as the derivation cohort, divided into training (80%) and internal validation (20%) sets, with 360 cases from another independent center for external validation. Feature selection was performed through recursive feature elimination with random forest algorithm. We employed six machine learning algorithms to develop the CMM risk model. Model performance was evaluated using accuracy, precision, recall, F1-score, and area under the curve (AUC). The SHapley Additive exPlanations (SHAP) and Local Interpretable Model-Agnostic Explanations (LIME) provided model interpretability. After feature screening, nine predictors were included in the model. In internal validation, the Stacking model achieved the highest AUC (0.868), maintaining good external validation performance with an AUC of 0.822. The web-based system was accessible on https://t2dmcmmpredictionweb.streamlit.app/ . This system assisted healthcare providers to identify high-risk populations early and facilitate timely intervention to mitigate disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.